Kenneth Edwards Westerman, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epigenomics | 2 | 2020 | 903 | 0.970 |
Why?
|
| DNA Methylation | 4 | 2020 | 4286 | 0.880 |
Why?
|
| Vitamin K 1 | 1 | 2020 | 48 | 0.720 |
Why?
|
| Food Analysis | 1 | 2020 | 104 | 0.710 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 15165 | 0.620 |
Why?
|
| Genome-Wide Association Study | 10 | 2023 | 12261 | 0.610 |
Why?
|
| Biological Specimen Banks | 2 | 2023 | 711 | 0.590 |
Why?
|
| Diet | 3 | 2023 | 7939 | 0.530 |
Why?
|
| Quantitative Trait Loci | 1 | 2022 | 2019 | 0.480 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 3647 | 0.430 |
Why?
|
| Dietary Fats | 1 | 2020 | 2017 | 0.410 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2023 | 11725 | 0.400 |
Why?
|
| Vitamins | 1 | 2020 | 1622 | 0.390 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1708 | 0.380 |
Why?
|
| Genetic Testing | 1 | 2020 | 3444 | 0.300 |
Why?
|
| CpG Islands | 2 | 2020 | 1172 | 0.260 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5751 | 0.240 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2023 | 26 | 0.230 |
Why?
|
| Software | 3 | 2022 | 4443 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2022 | 17446 | 0.210 |
Why?
|
| Genetic Loci | 2 | 2020 | 2575 | 0.190 |
Why?
|
| Prediabetic State | 1 | 2022 | 499 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2023 | 15519 | 0.140 |
Why?
|
| Phenotype | 3 | 2023 | 16365 | 0.140 |
Why?
|
| Eating | 1 | 2023 | 1536 | 0.140 |
Why?
|
| Fasting | 1 | 2022 | 1593 | 0.140 |
Why?
|
| Data Interpretation, Statistical | 2 | 2023 | 2716 | 0.130 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 1028 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15076 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2020 | 2634 | 0.120 |
Why?
|
| Humans | 18 | 2024 | 744343 | 0.120 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 1814 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1836 | 0.110 |
Why?
|
| Triglycerides | 1 | 2020 | 2454 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1519 | 0.100 |
Why?
|
| Incidence | 2 | 2020 | 20947 | 0.100 |
Why?
|
| Middle Aged | 8 | 2023 | 213383 | 0.100 |
Why?
|
| Female | 9 | 2023 | 380194 | 0.100 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 2356 | 0.090 |
Why?
|
| Women's Health | 1 | 2020 | 2034 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2023 | 40561 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2023 | 6077 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2020 | 23338 | 0.080 |
Why?
|
| Aged | 5 | 2020 | 163280 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2020 | 3188 | 0.080 |
Why?
|
| Genotype | 1 | 2022 | 12951 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2023 | 3445 | 0.080 |
Why?
|
| Male | 7 | 2023 | 350118 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12245 | 0.070 |
Why?
|
| Cluster Analysis | 2 | 2022 | 2715 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2020 | 8554 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6487 | 0.060 |
Why?
|
| Prevalence | 1 | 2020 | 15226 | 0.060 |
Why?
|
| Putrescine | 1 | 2022 | 40 | 0.060 |
Why?
|
| Acetylgalactosamine | 1 | 2022 | 37 | 0.050 |
Why?
|
| Taurine | 1 | 2022 | 94 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19905 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 314 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2023 | 53288 | 0.050 |
Why?
|
| Glucose | 2 | 2022 | 4397 | 0.050 |
Why?
|
| Sample Size | 1 | 2023 | 845 | 0.050 |
Why?
|
| Norway | 1 | 2020 | 448 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2022 | 462 | 0.040 |
Why?
|
| Diet, Vegetarian | 1 | 2020 | 174 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 11727 | 0.040 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2020 | 262 | 0.040 |
Why?
|
| Workflow | 1 | 2022 | 847 | 0.040 |
Why?
|
| Dietary Proteins | 1 | 2022 | 963 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1423 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57776 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2309 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2023 | 2072 | 0.030 |
Why?
|
| Metabolomics | 1 | 2022 | 1484 | 0.030 |
Why?
|
| Genome | 1 | 2022 | 1808 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2020 | 3920 | 0.020 |
Why?
|
| Weight Loss | 1 | 2022 | 2622 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 214055 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 4462 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2023 | 5102 | 0.020 |
Why?
|
| Genomics | 1 | 2023 | 5720 | 0.020 |
Why?
|
| Insulin | 1 | 2022 | 6580 | 0.020 |
Why?
|
| Exercise | 1 | 2023 | 5615 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 9438 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9959 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 12072 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12745 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25043 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 29786 | 0.010 |
Why?
|
| Risk Factors | 1 | 2023 | 72290 | 0.010 |
Why?
|
| United States | 1 | 2022 | 69872 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 56430 | 0.010 |
Why?
|